Skip to main content
OpenTrials
Completed

NCT Number: NCT01693302

Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes

Blood glucose levels in patients with type 1 diabetes tend to peak after eating a meal due to the delayed action of insulin when compared to carbohydrate absorption from food. It is the hypothesis of the investigator that administering the insulin for a meal 20 minutes before the meal will result in lower blood glucose peaks compared to administration of insulin immediately before or 20 minutes after starting to eat.

All subjects will eat the same meal on three different occasions. Insulin will be administered at one of the three times at each visit.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Barbara Davis Center

Aurora, Colorado, 80045, United States

About this study

Subjects enrolled in this study will be between the ages of 12 and 30 years inclusive. All subjects will be on an insulin pump and use carbohydrate counting as their method for insulin dosing at a meal.

Subjects in this study will complete three study visits lasting from approximately 8:30am until 1:30pm. At each visit, the subject will eat the same frozen breakfast meal. Subjects will be supplied with the same insulin to maintain consistency between visits and between subjects.

Insulin will be administered at different times, depending upon the randomization group assigned to the participant. The three different times the insulin will be given is either 20 minutes before the meal, immediately before the meal and 20 minutes after the meal. All subjects will complete all three insulin bolus times. Blood glucose will be measured by fingerstick every 30 minutes until the completion of the visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 12 to 30 years of age, inclusive
  • Clinical diagnosis of T1D and using daily insulin therapy for at least 1 year
  • Using carbohydrate counting to dose meal time insulin
  • HbA1c value upon enrollment greater than 6.0% and less than 12.0%
  • Using CSII therapy for diabetes management for at least three months
  • Able and willing to give informed consent/assent to participate
  • No expectation that the subject will be moving out of the area of the clinical center during the study
  • Willing to consume the same standard frozen meal on all three visits

Exclusion criteria

  • The presence of a significant medical disorder that in the judgment of the investigator will affect the wearing of the CGMS sensors or the completion of any aspect of the protocol
  • Being unable or unwilling to give informed consent
  • Having documented hypoglycemia unawareness
  • An episode of severe hypoglycemia (seizure or loss of consciousness) or of ketoacidosis in the past six months

Treatment and study plan

Insulin

Other

The timing of insulin delivery varies with each study visit. The dose is given based on carbohydrate content and blood glucose level. The insulin is given either 20 minutes before the meal, immediately before the meal, or 20 minutes after the meal.

Other names: Insulin time

Primary outcomes

  1. Blood glucose area under the curve

    Time frame: 9:00am until 1:30pm

Secondary outcomes

  1. Glucose values one hour after the meal

    Time frame: 10:30am

  2. Glucose values two hours after the beginning of the meal

    Time frame: 11:30am

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

  • Sanofi

Registry information

Official study title

Timing of Meal Insulin Boluses to Achieve Optimal Postprandial Glycemic Control in Patients With Type 1 Diabetes

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Sep 26, 2012
Registry last updated
Sep 26, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.